The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I- associated epitopes

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6462-6467

  Loyer, Véronique ^a   Fontaine, Pierre ^a   Pion, Stéphane ^a   Hétu, Francis ^a   Roy, Denis Claude ^a   Perreault, Claude ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNOMODULATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL SURVIVAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNODOMINANT EPITOPES; INJECTIONS, SUBCUTANEOUS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MINOR HISTOCOMPATIBILITY ANTIGENS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032742010     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Gordon, S. 1999. Macrophages and the immune response. In Fundamental Immunology, 4th Ed. W. E. Paul, ed. Lippincott-Raven, Philadelphia, p. 533.
3. + T cell priming in vivo. J. Immunol. 162:5695.
4. Zinkernagel, R. M., S. Ehl, P. Aichele, S. Oehen, T. Kundig, and H. Hengartner. 1997. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156; 199.
5. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89.
6. Ehl, S., P. Klenerman, P. Aichele, H. Hengartner, and R. M. Zinkernagel. 1997. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 27:3404.
7. + T cells in primary and secondary influenza pneumonia. Immunity 8:683.
8. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, et al. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.
9. Oddo, M., T. Renno, A. Atlinger, T. Bakker, H. R. MacDonald, and P. R. A. Meylan. 1998. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160:5448.
10. + T cells. Eur. J. Immunol. 23:3306.
11. Rocha, B., A. Grandien, and A. A. Freitas. 1995. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 181:993.
12. + T cells limits their cytokine synthesis and proliferation. J. Exp. Med. 184:1543.
13. + lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc. Natl. Acad. Sci. USA 92:11225.
14. + T cells. J. Immunol. 162:5287.
15. + T cells. J. Exp. Med. 185:2133.
16. Tanchot, C., F. A. Lemonnier, B. Perarnau, A. A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057.
17. Fortier, A. H., and L. A. Falk. 1994. Isolation of murine macrophages. In Current Protocols in Immunology. C. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Greene Publishing and Wiley-Interscience, New York, p. 14.1.1.
18. Wahl, L. M., and P. D. Smith. 1995. Isolation of monocyte/macrophage populations. In Current Protocols in Immunology. C. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Greene Publishing and Wiley-Interscience, New York, p. 7.6.1.
19. Kay, G. F., A. Ashworth, G. D. Penny, M. Dunlop, S. Swift, N. Brockdorff, and S. Rastan. 1991. A candidate spermatogenesis gene on the mouse Y chromosome is homologous to ubiquitin-activating enzyme E1. Nature 354:486.
20. Mitchell, M. J., D. R. Woods, P. K. Tucker, J. S. Opp, and C. E. Bishop. 1991. Homology of a candidate spermatogenic gene from the mousechromosome to the ubiquitin-activating enzyme E1. Nature 354:483.
21. Hétu, F., F. Coutlee, and D. C. Roy. 1994. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma. Mol. Cell Probes 8:449.
22. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237.
23. Léonard, B. M., F. Hétu, L. Busque, M. Gyger, R. Bélanger, C. Perreault, and D. C. Roy. 1998. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood 91:331.
24. Usherwood, E. J., T. L. Hogg, and D. L. Woodland. 1999. Enumeration of antigen-presenting cells in mice infected with Sendai virus. J. Immunol. 162:3350.
25. van Vugt, E., M. A. Verdaasdonk, R. H. Beelen, and E. W. Kamperdijk. 1992. Induction of an increased number of dendritic cells in the peritoneal cavity of rats by intraperitoneal administration of bacillus Calmette-Guérin. Immunobiology 186:230.
26. Correa, S. G., C. M. Riera, and P. Iribarren. 1997. Involvement of peritoneal dendritic cells in the induction of autoimmune prostatitis. J. Autoimmun. 10:107.
27. Simpson, E. 1982. The role of H-Y as a minor transplantation antigen. Immunol. Today 3:97.
28. Hansen, T. H., D. G. Spinella, D. R. Lee, and D. C. Shreffler. 1984. The immunogenetics of the mouse major histocompatibility gene complex. Annu. Rev. Genet. 18:99.
29. - cells in vitro and in vivo. Immunol. Rev. 91:195.
30. Wise, M., D. Zelenika, F. Bemelman, D. Latinne, H. Bazin, S. Cobbold, and H. Waldmann. 1999. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts. Eur. J. Immunol. 29:156.
31. Levitsky, V., Q. J. Zhang, J. Levitskaya, and M. G. Masucci. 1996. The life span of major histocompalibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183: 915.
32. + cytotoxic T cell with apparent high affinity. J. Immunol. 158:5797.
33. Pion, S., P. Fontaine, M. Desaulniers, J. Jutras, J. G. Filep, and C. Perreault. 1997. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur. J. Immunol. 27:421.
34. Pion, S., G. J. Christianson, P. Fontaine, D. C. Roopenian, and C. Perreault. 1999. Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens. Blood 93: 952.
35. Perreault, C., J. Jutras, D. C. Roy, J. G. Filep, and S. Brochu. 1996. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA): T cell response to a single dominant MiHA causes graft-versus-host disease. J. Clin. Invest. 98:622.
36. Snell, G. D., and H. P. Bunker. 1965. Histocompatibility genes of the mouse. V. Five new histocompatibility loci identified by congenic resistant lines on a C57BL/10 background. Transplantation 3:235.
37. dom 1) encoded by the classical H7 minor histocompatibility locus. J. Immunol. 162:4502.
38. Sprent, J., M. Schaefer, D. Lo, and R. Korngold. 1986. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J. Exp. Med. 163:998.
39. Selvaggi, G., C. Ricordi, E. R. Podack, and L. Inverardi. 1996. The role of the perform and Fas pathways of cytotoxicily in skin graft rejection. Transplantation 62:1912.
40. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
41. Bachmann, M. F., T. Ohteki, K. McKall-Faienza, A. Zakarian, D. Kagi, D. E. Speiser, and P. S. Ohashi. 1997. Altered peptide ligands trigger perforin-rather than Fas-dependent cell lysis. J. Immunol. 159:4165.
42. Sutton, V. R., D. L. Vaux, and J. A. Trapani. 1997. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J. Immunol. 158:5783.
43. Armitage, R. J. 1994. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6:407.
44. Blanchard, D. K., S. Wei, C. Duan, F. Pericle, J. I. Diaz, and J. Y. Djeu. 1995. Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells. Blood 85:3173.
45. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158:5283.
46. Nakamoto, Y., L. G. Guidotti, V. Pasquetto, R. D. Schreiber, and F. V. Chisari. 1997. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158:5692.
47. Pettersen, R. D., G. Gaudernack, M. K. Olafsen, S. O. Lie, and K. Hestdal. 1998. The TCR-binding region of the HLA class I α2 domain signals rapid Fas-independent cell death: a direct pathway for T cell-mediated killing of target cells? J. Immunol. 160:4343.
48. Edwards, K. M., J. E. Davis, K. A. Browne, V. R. Sutton, and J. A. Trapani. 1999. Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction. Immunol. Cell Biol. 77:76.
49. Perreault, C., D. C. Roy, and C. Fortin. 1998. Immunodominant minor histocompatibility antigens: the major ones. Immunol. Today 19:69.
50. Pion, S., P. Fontaine, C. Baron, M. Gyger, and C. Perreault. 1995. Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy. J. Clin. Invest. 95:1561.
51. Oukka, M., J. C. Manuguerra, N. Livaditis, S. Tourdot, N. Riche, I. Vergnon, P. Cordopatis, and K. Kosmatopoulos. 1996. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J. Immunol. 157:3039.
52. Pewe, L., G. F. Wu, E. M. Barnett, R. F. Castro, and S. Perlman. 1996. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity. 5:253.
53. Wolpert, E. Z., P. Grufman, J. K. Sandberg, A. Tegnesjö, and K. Kärre. 1998. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J. Immunol. 161:4499.
54. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
55. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51.
56. Wettstein, P. J. 1995. Murine minor histocompatibility antigens detected by helper T cells: recognition of an endogenous peptide. J. Immunol. 154:2134.
57. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19:395.